Nuwellis (NUWE) Receives USPTO Notice of Patent Allowance for Innovative Pediatric CRRT Technology

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/3/2026

1. KRG
2. CCHGY
3. PRY:IM
4. PRYMY
5. SPY
6. ALAR
7. CCH:LN
8. META
9. AXTI
10. MIN

Go back to Nuwellis (NUWE) Receives USPTO Notice of Patent Allowance for Innovative Pediatric CRRT Technology

Nuwellis Receives USPTO Notice of Patent Allowance for Innovative Pediatric CRRT Technology

May 2, 2024 9:00 AM EDT

MINNEAPOLIS, May 02, 2024 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company dedicated to transforming the lives of patients suffering from fluid overload, today announced that it has received a Notice of Allowance from the U.S. Patent and Trademark Office (USPTO) for a patent application related to its innovative pediatric Continuous Renal Replacement Therapy (CRRT) device branded Vivian. This patent strengthens Nuwellis' intellectual... More